Skip to main content

Internalizing Symptoms in Early Teens Tied to Later Cardiometabolic Risk Factors

Medically reviewed by Drugs.com.

By Lori Solomon HealthDay Reporter

FRIDAY, Oct. 13, 2023 -- Internalizing symptoms among Latinx youth during early adolescence relate to health behaviors and outcomes underlying cardiometabolic risk during middle and late adolescence, according to a study published online Oct. 10 in the Journal of Adolescent Health.

Kathleen M. Roche, Ph.D., from the Milken Institute School of Public Health at George Washington University in Washington, D.C., and colleagues examined how Latinx youth's internalizing symptoms during early adolescence are related to sleep problems, overweight/obesity, sedentary behavior, physical activity, healthy diet, and hypertension or diabetes risk during middle and late adolescence. The analysis included survey results from 547 Hispanic adolescents.

The researchers found that early adolescent internalizing symptoms were associated positively with later sleep problems (ß = 0.36), overweight/obesity (adjusted odds ratio, 2.57), sedentary behavior (ß = 0.19), and internalizing symptoms (ß = 0.48). There was an inverse association with early adolescent internalizing symptoms and later physical activity (ß = −0.16) and a healthy diet (ß = −0.21).

"Explanations for the onset and progression of chronic diseases of aging are multifactorial and complex," the authors write. "Results from this study suggest the potential value of public health interventions that move beyond lifestyle behaviors and directly address mental health during the early adolescent years."

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Posted October 2023

Read this next

Semaglutide Cuts Risk for Kidney Outcomes, Death in CKD With T2DM

FRIDAY, May 31, 2024 -- For patients with type 2 diabetes and chronic kidney disease, semaglutide reduces the risk for clinically important kidney outcomes and death from...

DNA Methylation-Based Epigenetic Age Mediates Link Between LE8 Score, CVD

WEDNESDAY, May 29, 2024 -- The associations between Life's Essential 8 (LE8) and cardiovascular health are mediated by DNA methylation-based epigenetic age, according to a study...

Semaglutide Boosts Kidney Outcomes With Obesity + Cardiovascular Disease

TUESDAY, May 28, 2024 -- Once-weekly subcutaneous semaglutide shows a benefit for kidney outcomes in people with overweight or obesity and established cardiovascular disease...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.